These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11990828)

  • 41. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction.
    Dotan ZA; Mor Y; Leibovitch I; Varon D; Golomb J; Duvdevani M; Ramon J
    J Urol; 2002 Aug; 168(2):610-3; discussion 614. PubMed ID: 12131319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
    Saxena AK; Panhotra BR
    J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
    Shah PS; Kalyn A; Satodia P; Dunn MS; Parvez B; Daneman A; Salem S; Glanc P; Ohlsson A; Shah V
    Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pregnancy, heparin and osteoporosis.
    Schulman S; Hellgren-Wångdahl M
    Thromb Haemost; 2002 Feb; 87(2):180-1. PubMed ID: 11858474
    [No Abstract]   [Full Text] [Related]  

  • 45. [Management of heparin-induced thrombocytopenia in a patient on hemodialysis complicated with thrombosis in the extracorporeal circuit].
    César JM; Candela A; Tenorio MT; Chinea A; Sáiz R; Liaño F
    Nefrologia; 2008; 28(4):462-3. PubMed ID: 18662159
    [No Abstract]   [Full Text] [Related]  

  • 46. Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery 'spontaneous' HIT.
    Pruthi RK; Daniels PR; Nambudiri GS; Warkentin TE
    J Thromb Haemost; 2009 Mar; 7(3):499-501. PubMed ID: 19087219
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
    Davidson BL; Büller HR; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob GE; Segers AE; Lensing AW;
    J Thromb Haemost; 2007 Jun; 5(6):1191-4. PubMed ID: 17403087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants.
    Büller HR; Halperin JL; Bounameaux H; Prins M
    J Thromb Haemost; 2008 Feb; 6(2):227-9. PubMed ID: 18034770
    [No Abstract]   [Full Text] [Related]  

  • 49. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
    Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
    Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
    Pruemer J
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripartum and perioperative management of the anticoagulated patient.
    Chasen ST
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):493-7, x-xi. PubMed ID: 16962924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 53. Thromboprophylaxis in medical-surgical intensive care unit patients.
    Cook D; Crowther MA; Douketis J;
    J Crit Care; 2005 Dec; 20(4):320-3. PubMed ID: 16310602
    [No Abstract]   [Full Text] [Related]  

  • 54. Bridging of oral anticoagulation therapy for invasive procedures.
    Spyropoulos AC
    Curr Hematol Rep; 2005 Sep; 4(5):405-13. PubMed ID: 16131443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticoagulant drugs.
    Br Med J; 1969 Feb; 1(5640):365-7. PubMed ID: 5762842
    [No Abstract]   [Full Text] [Related]  

  • 56. [The use of anticoagulants in the chemotherapy of cancer].
    Grekh IF; Shats VIa
    Vopr Onkol; 1969; 15(1):111-6. PubMed ID: 4891306
    [No Abstract]   [Full Text] [Related]  

  • 57. Antithrombin deficiency in special clinical syndromes--Part I: panel discussion.
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):37-41. PubMed ID: 8821208
    [No Abstract]   [Full Text] [Related]  

  • 58. Perioperative Management of the Direct Oral Anticoagulants: A Case-Based Review.
    Bell BR; Spyropoulos AC; Douketis JD
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1073-84. PubMed ID: 27637308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recurrent thrombosis of biventricular-support devices associated with accelerated intravascular coagulation and increased heparin requirements.
    Despotis GJ; Levine V; Alsoufiev A; Joist H; Goodnough LT; Pasque M
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):538-40. PubMed ID: 8751525
    [No Abstract]   [Full Text] [Related]  

  • 60. Heparin therapy.
    Korst DR; Raich PC
    Wis Med J; 1972 Jul; 71(7):188-90. PubMed ID: 5040595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.